{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:40:23Z","timestamp":1793313623579,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41390-025-04312-6","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:50:23Z","timestamp":1753275023000},"page":"1051-1059","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Gastrointestinal safety of oral erythromycin, clarithromycin, and azithromycin in pediatric patients: a FAERS pharmacovigilance study"],"prefix":"10.1038","volume":"99","author":[{"given":"Zhu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"4312_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/QCO.0000000000001087","volume":"38","author":"N Antonakos","year":"2025","unstructured":"Antonakos, N., Giamarellos-Bourboulis, E. J. & Niederman, M. S. The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplasma pneumoniae. Curr. Opin. Infect. Dis. 38, 190\u2013197 (2025).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"4312_CR2","doi-asserted-by":"publisher","first-page":"2386636","DOI":"10.1080\/07853890.2024.2386636","volume":"56","author":"L Gao","year":"2024","unstructured":"Gao, L. & Sun, Y. Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review. Ann. Med. 56, 2386636 (2024).","journal-title":"Ann. Med."},{"key":"4312_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jgar.2024.07.016","volume":"38","author":"NA Nor Amdan","year":"2024","unstructured":"Nor Amdan, N. A., Shahrulzamri, N. A., Hashim, R. & Mohamad Jamil, N. Understanding the evolution of macrolides resistance: a mini review. J. Glob. Antimicrob. Resist. 38, 368\u2013375 (2024).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"4312_CR4","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1093\/jac\/dkae315","volume":"79","author":"A Wiesner","year":"2024","unstructured":"Wiesner, A., Zagrodzki, P., Gawalska, A. & Pasko, P. Clinically important interactions of macrolides and tetracyclines with dietary interventions-a systematic review with meta-analyses. J. Antimicrob. Chemother. 79, 2762\u20132791 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"4312_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2024.02.003","volume":"30","author":"L Moja","year":"2024","unstructured":"Moja, L. et al. WHO\u2019s essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections. Clin. Microbiol. Infect. 30, S1\u2013S51 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"4312_CR6","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.21037\/tp-21-444","volume":"10","author":"D Li","year":"2021","unstructured":"Li, D. & Wang, Y. Safety of azithromycin in pediatric infectious diseases: a clinical systematic review and meta-analysis. Transl. Pediatr. 10, 2594\u20132601 (2021).","journal-title":"Transl. Pediatr."},{"key":"4312_CR7","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1542\/hpeds.2023-007627","volume":"14","author":"AR Roberts","year":"2024","unstructured":"Roberts, A. R. et al. Azithromycin for pediatric critical asthma: a multicenter retrospective cohort study. Hosp. Pediatr. 14, e254\u2013e259 (2024).","journal-title":"Hosp. Pediatr."},{"key":"4312_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41390-023-02953-z","volume":"95","author":"RM Ukkonen","year":"2024","unstructured":"Ukkonen, R. M., Renko, M. & Kuitunen, I. Azithromycin for acute bronchiolitis and wheezing episodes in children - a systematic review with meta-analysis. Pediatr. Res. 95, 1441\u20131447 (2024).","journal-title":"Pediatr. Res."},{"key":"4312_CR9","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s00431-024-05519-1","volume":"183","author":"G Ding","year":"2024","unstructured":"Ding, G. et al. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia. Eur. J. Pediatr. 183, 3001\u20133011 (2024).","journal-title":"Eur. J. Pediatr."},{"key":"4312_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.resinv.2024.09.004","volume":"62","author":"N Nakagawa","year":"2024","unstructured":"Nakagawa, N. et al. Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis. Respir. Investig. 62, 1079\u20131087 (2024).","journal-title":"Respir. Investig."},{"key":"4312_CR11","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1111\/bcp.16153","volume":"90","author":"SF Ramos","year":"2024","unstructured":"Ramos, S. F. et al. Moderate and serious adverse reactions to antimicrobials among hospitalized children: a systematic review. Br. J. Clin. Pharmacol. 90, 2092\u20132110 (2024).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"4312_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1120009X.2019.1680116","volume":"32","author":"K Eljaaly","year":"2020","unstructured":"Eljaaly, K. et al. Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia. J. Chemother. 32, 1\u20136 (2020).","journal-title":"J. Chemother."},{"key":"4312_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1473-3099(22)00735-6","volume":"23","author":"EL Tsalik","year":"2023","unstructured":"Tsalik, E. L. et al. Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial. Lancet Infect. Dis. 23, 484\u2013495 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"4312_CR14","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00228-020-02956-3","volume":"76","author":"L Zeng","year":"2020","unstructured":"Zeng, L. et al. Safety of azithromycin in pediatrics: a systematic review and meta-analysis. Eur. J. Clin. Pharmacol. 76, 1709\u20131721 (2020).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"4312_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.resinv.2023.12.015","volume":"62","author":"Y Fukuda","year":"2024","unstructured":"Fukuda, Y. et al. Efficacy and safety of macrolide therapy for adult asthma: a systematic review and meta-analysis. Respir. Investig. 62, 206\u2013215 (2024).","journal-title":"Respir. Investig."},{"key":"4312_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/17512433.2015.992878","volume":"8","author":"VK Patadia","year":"2014","unstructured":"Patadia, V. K. et al. Using real-world healthcare data for pharmacovigilance signal detection \u2013 the experience of the EU-ADR project. Expert Rev. Clin. Pharmacol. 8, 95\u2013102 (2014).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"4312_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/andr.13533","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Zhao, B., Yang, H. & Wan, Z. A real-world pharmacovigilance study of FDA Adverse Event Reporting System events for sildenafil. Andrology 12, 785\u2013792 (2024).","journal-title":"Andrology"},{"key":"4312_CR18","doi-asserted-by":"publisher","first-page":"1333662","DOI":"10.3389\/fphar.2024.1333662","volume":"15","author":"B Zhao","year":"2024","unstructured":"Zhao, B. et al. A real-world disproportionality analysis of Everolimus: data mining of the public version of FDA Adverse Event Reporting System. Front. Pharmacol. 15, 1333662 (2024).","journal-title":"Front. Pharmacol."},{"key":"4312_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/17425255.2023.2219390","volume":"19","author":"H Yang","year":"2023","unstructured":"Yang, H. et al. A real-world data analysis of topotecan in the FDA Adverse Event Reporting System (FAERS) database. Expert Opin. Drug Metab. Toxicol. 19, 217\u2013223 (2023).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"4312_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/bcp.13098","volume":"83","author":"P In\u00e1cio","year":"2017","unstructured":"In\u00e1cio, P., Cavaco, A. & Airaksinen, M. The value of patient reporting to the pharmacovigilance system: a systematic review. Br. J. Clin. Pharmacol. 83, 227\u2013246 (2017).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"4312_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda, T., Tamon, A., Kadoyama, K. & Okuno, Y. Data mining of the public version of the FDA Adverse Event Reporting System. Int. J. Med. Sci. 10, 796\u2013803 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"4312_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pds.1001","volume":"13","author":"KJ Rothman","year":"2004","unstructured":"Rothman, K. J., Lanes, S. & Sacks, S. T. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol. Drug Saf. 13, 519\u2013523 (2004).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"4312_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown, E. G., Wood, L. & Wood, S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 20, 109\u2013117 (1999).","journal-title":"Drug Saf."},{"key":"4312_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-13-138","volume":"13","author":"S Singh","year":"2012","unstructured":"Singh, S. & Loke, Y. K. Drug safety assessment in clinical trials: methodological challenges and opportunities. Trials 13, 1\u20138 (2012).","journal-title":"Trials"},{"key":"4312_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/0018578718795271","volume":"54","author":"A Kumar","year":"2019","unstructured":"Kumar, A. The newly available FAERS public dashboard: implications for health care professionals. Hosp. Pharm. 54, 75\u201377 (2019).","journal-title":"Hosp. Pharm."},{"key":"4312_CR26","first-page":"1","volume":"10","author":"KA Kagkelaris","year":"2018","unstructured":"Kagkelaris, K. A., Makri, O. E., Georgakopoulos, C. D. & Panayiotakopoulos, G. D. An eye for azithromycin: review of the literature. Ther. Adv. Ophthalmol. 10, 1\u201314 (2018).","journal-title":"Ther. Adv. Ophthalmol."},{"key":"4312_CR27","first-page":"1","volume":"7","author":"KM Shaeer","year":"2019","unstructured":"Shaeer, K. M., Chahine, E. B., Varghese Gupta, S. & Cho, J. C. Macrolide allergic reactions. Pharmaceuticals7, 1\u201323 (2019).","journal-title":"Pharmaceuticals"},{"key":"4312_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1939-4551-8-S1-A222","volume":"8","author":"A Assa\u2019ad","year":"2015","unstructured":"Assa\u2019ad, A. Three cases with three different causes of lip and mouth swelling. World Allergy Organ. J. 8, A222 (2015).","journal-title":"World Allergy Organ. J."},{"key":"4312_CR29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3109\/00016357.2016.1172342","volume":"74","author":"E Wuollet","year":"2016","unstructured":"Wuollet, E., Laisi, S., Salmela, E., Ess, A. & Alaluusua, S. Molar-incisor hypomineralization and the association with childhood illnesses and antibiotics in a group of Finnish children. Acta Odontol. Scand. 74, 416\u2013422 (2016).","journal-title":"Acta Odontol. Scand."},{"key":"4312_CR30","unstructured":"National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease in children and young people: diagnosis and management. NICE Guideline [NG1]. https:\/\/www.nice.org.uk\/guidance\/ng1 (2015)."},{"key":"4312_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000510580","volume":"28","author":"V Zimmer","year":"2021","unstructured":"Zimmer, V. & Emrich, K. Azithromycin-induced pill esophagitis. GE Port. J. Gastroenterol. 28, 225\u2013226 (2021).","journal-title":"GE Port. J. Gastroenterol."},{"key":"4312_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1053\/j.gastro.2016.02.029","volume":"150","author":"M Camilleri","year":"2016","unstructured":"Camilleri, M. et al. Pharmacological, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders. Gastroenterology 150, 1319\u20131331 (2016).","journal-title":"Gastroenterology"},{"key":"4312_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1001\/jamasurg.2015.0306","volume":"150","author":"C Czarnetzki","year":"2015","unstructured":"Czarnetzki, C. et al. Erythromycin for gastric emptying in patients undergoing general anesthesia for emergency surgery: A randomized clinical trial. JAMA Surg. 150, 730\u2013737 (2015).","journal-title":"JAMA Surg."},{"key":"4312_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0884533611399924","volume":"26","author":"S van den Bosch","year":"2011","unstructured":"van den Bosch, S., Witteman, E., Kho, Y. & Tan, A. C. Erythromycin to promote bedside placement of a self-propelled nasojejunal feeding tube in non-critically ill patients having pancreatitis: a randomized, double-blind, placebo-controlled study. Nutr. Clin. Pract. 26, 181\u2013185 (2011).","journal-title":"Nutr. Clin. Pract."},{"key":"4312_CR35","doi-asserted-by":"publisher","first-page":"103601","DOI":"10.1016\/j.amsu.2022.103601","volume":"77","author":"AMH Dirie","year":"2022","unstructured":"Dirie, A. M. H., Abdinur, A. H., Osman, M. A. & Idiris, M. H. Clarithromycin induced acute pancreatitis: a rare side effect. Case report. Ann. Med. Surg.77, 103601 (2022).","journal-title":"Ann. Med. Surg."},{"key":"4312_CR36","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1001\/jamainternmed.2020.1835","volume":"180","author":"K Hill","year":"2020","unstructured":"Hill, K. et al. Risk of hospitalization with hemorrhage among older adults taking clarithromycin vs azithromycin and direct oral anticoagulants. JAMA Intern. Med. 180, 1052\u20131060 (2020).","journal-title":"JAMA Intern. Med."},{"key":"4312_CR37","doi-asserted-by":"publisher","first-page":"bcr2013200731","DOI":"10.1136\/bcr-2013-009984","volume":"2013","author":"R Miyauchi","year":"2013","unstructured":"Miyauchi, R., Kinoshita, K. & Tokuda, Y. Clarithromycin-induced haemorrhagic colitis. BMJ Case Rep. 2013, bcr2013200731 (2013).","journal-title":"BMJ Case Rep."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04312-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04312-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04312-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:22:02Z","timestamp":1774527722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04312-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4312"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04312-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}